Specialty / Expertise

Lung, Head and Neck Cancers

Research Interests

Current Research Projects

Lilly - Early positron emission tomography as a predictor of response in neoadjuvant chemotherapy for NSCLC.

Amgen - Phase 2, Open-label study of AMG 708 to treat subjects with locally advanced or metastatic thyroid cancer.

Dana-Farber - A phase II, open label study of gefitinib (IRESSA) in treatment-naive subjects with stage IIIB or IV non-small cell lung cancer and somatic activating mutations in the epidermal growth factor receptor.

Genentech - A multicenter randomized phase II study of erlotinib, cisplatin, and radiotherapy versus cisplatin and radiotherapy in patients with stage III and IV squamous cell carcinoma of the head and neck

Research Staff

Training

Dr. Martins received his MD from Federal University of Rio de Janiero, Brazil. He completed his Internal Medicine Residency at Gundersen Clinic, La Crosse, WI . He was a Post-Doctoral Fellow in Hematology/Oncology at Massachuesetts General/Harvard Medical School, Boston, MA.

Selected Publications:

Till BG, Martins RG. Repsonse to paclitaxel in adenoid cystic carcinoma of the salivary glands. Heck Neck 2007 Nov 2; [Epub ahead of print]

Bauman JE, Eaton KD, Martins RG. Antagonism of platelet-derived growth factor receptor in non-small cell lung cancer: rationale and investigations. Clin Cancer Res 2007 13(15 Pt2):s4632-s4636.

Bauman JE, Eaton KD, Martins RG. Treatment of recurrent squamous cell carcinoma of the skin with cetuximab: report of two cases. Arch Derm 2007 143(7):889-892.

Martins RG, Dienstmann R, de Biasi P, Dantas K, Santos V, Toscano E, Roriz W. Zamboni M, Sousa A, Smaill IA, Moreira D, Ferreira CG, Zukin M. Phase II trial of neoadjuvant chemotherapy using alternating doublet in non-small-cell lung cancer. Clinical Lung Cancer, 2007 Jan;8(4):257-63.

Martins RG, Rajendran JG, Capell P, Byrd DR, Mankoff DA. Medullary thyroid cancer: options for systemic therapy of metastatic disease? J Clin Oncol 2006 Apr 10;24(11):1653-5.